Objective: To compare white-matter integrities between schizophrenic patients maintained treated with chlorpromazine and clozapine by tract-based spatial statistics. Methods: The patients with schizophrenia in stable condition that received maintenance treatment with chlorpromazine and clozapine and normal control subjects were recruited(n=24 per groups). DTI data were acquired using a 3T MR system(GE HDx, Milwaukee, WI). The differences in white-matter integrities were analyzed by TBSS(tract-based spatial statistics), while their correlations to clinical symptoms were also investigated. Results: There was no statistical significances in PANSS and SSPI and white-matter values(FA, DA, DR and MD) between the chlorpromazine and clozapine treated groups. Compared with control group, FA was significantly lower in Body of corpus callosum, Genu of corpus callosum, Cingulum L, and Cingulum L in chlorpromazine group. FA was remarkably lower in Body of corpus callosum, Genu of corpus callosum, Splenium of corpus callosum, Superior corona radiata L&R, Posterior thalamic radiation L&R, Superior longitudinal fasciculus L, Cingulum L&R in clozapine group. Compared with control group, clozapine group had the significant higher DA in Fornix and Posterior limb of internal capsule L; the significant higher DR in Body of corpus callosum, Genu of corpus callosum, Splenium of corpus callosum, Superior corona radiata L&R, Posterior thalamic radiation L&R; and the significant higher MD in Body of corpus callosum, Genu of corpus callosum, Superior corona radiata L&R, and Posterior thalamic radiation L. The FA value of Posterior thalamic radiation was negatively correlated with PANSS positive score in clozapine group (r=-0.697,P <0.01). Conclusions: Schizophrenic patients have deficits of white-matter integrities in the period of maintenance treatment. The severer impairments of white-matter integrities in clozapine treated patients might be one of pathological mechanism underlying their refractory symptoms. |
[1] 夏雪涛,旷昌珍,喻体莲,等.齐拉西酮与氯丙嗪对首发精神分裂症患者认知功能影响的对照研究[J].现代医学,2011,39(1):69-71.
[2] LEUCHT S,CIPRIANI A,SPINELI L,et al.Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia:a multiple-treatments meta-analysis[J].Lancet,2013,382(9896):951-962.
[3] SMITH S M,JENKINSON M,JOHANSEN-BERG H,et al.Tract-based spatial statistics:voxelwise analysis of multi-subject diffusion data[J].Neuro Image,2006,31(4):1487-1505.
[4] CUI Z,ZHONG S,XU P,et al.PANDA:a pipeline toolbox for analyzing brain diffusion images[J].Front Hum Neurosci,2013,7:42.
[5] KUROKI T,NAGAO N,NAKAHARA T.Neuropharmacology of second-generation antipsychotic drugs:a validity of the serotonin-dopamine hypothesis[J].Prog Brain Res,2008,172:199-212.
[6] CHEUNG V,CHEUNG C,McALONAN G M,et al.A diffusion tensor imaging study of structural dysconnectivity in never-medicated,first-episode schizophrenia[J].Psychol Med,2008,38(6):877-885.
[7] GASPAROTTI R,VALSECCHI P,CARLETTI F,et al.Reduced fractional anisotropy of corpus callosum in first-contact,antipsychotic drug-naive patients with schizophrenia[J].Schizophr Res,2009,108(1-3):41-48.
[8] FRIEDMAN J I,TANG C,CARPENTER D,et al.Diffusion tensor imaging findings in first-episode and chronic schizophrenia patients[J].Am J Psychiatry,2008,165(8):1024-1032.
[9] 扬帆,李培凯,侯瑜,等.慢性精神分裂症磁共振弥散张量成像及其与临床症状的相关分析[J].中华精神科杂志,2014,47(1):26-30.
[10] ELLISON-WRIGHT I,BULLMORE E.Meta-analysis of diffusion tensor imaging studies in schizophrenia[J].Schizophr Res,2009,108(1-3):3-10.
[11] KYRIAKOPOULOS M,BARGIOTAS T,Barker GJ,et al.Diffusion tensor imaging in schizophrenia[J].Eur Psychiatry,2008,23(4):255-273.
[12] WANG Q,CHEUNG C,DENG W,et al.White-matter microstructure in previously drug-naive patients with schizophrenia after 6 weeks of treatment[J].Psychol Med,2013,43(11):2301-2309.
[13] MINAMI T,NOBUHARA K,OKUGAWA G,et al.Diffusion tensor magnetic resonance imaging of disruption of regional white matter in schizophrenia[J].Neuropsychobiology,2003,47(3):141-145.
[14] WHITE T,MAGNOTTA V A,BOCKHOLT H J,et al.Global white matter abnormalities in schizophrenia:a multisite diffusion tensor imaging study[J].Schizophr Bull,2011,37(1):222-232.
[15] KANAAN R,BARKER G,BRAMMER M,et al.White matter microstructure in schizophrenia:effects of disorder,duration and medication[J].Br J Psychiatry,2009,194(3):236-242.
[16] BRICKMAN A M,BUCHSBAUM M S,IVANOV Z,et a1.Internal capsule size in good-outcome and poor-outcome schizophrenia[J].J Neuropsychiatry Clin Neurosci,2006,18(3):364-376.
[17] REIS-MARQUES T,TAYLOR H,CHADDOCK C,et al.White matter integrity as a predictor of response to treatment in first episode psychosis[J].Brain,2014,137(Pt 1):172-182.
[18] OZCELIK-EROGLU E,ERTUGRUL A,OGUZ K K,et al.Effect of clozapine on white matter integrity in patients with schizophrenia:a diffusion tensor imaging study[J].Psychiatry Res,2014,223 (3):226-235.
[19] WHITE T,EHRLICH S,HO B C,et al.Spatial characteristics of white matter abnormalities in schizophrenia[J].Schizophr Bull,2013,39(5):1077-1086.
[20] KUBOTA M,MIYATA J,SASAMOTO A,et al.Alexithymia and reduced white matter integrity in schizophrenia:a diffusion tensor imaging study on impaired emotional self-awareness[J].Schizophr Res,2012,141(2-3):137-143. |